Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Dr Chris Laing

Chief Executive Officer

As Chief Executive Officer of UCLPartners, Chris leads our work as a partnership to improve the health of our population through the implementation of research and innovation into practice. He joined UCLPartners in October 2021, initially as Director of our Academic Health Science Network and National Director of the NHS Innovation Accelerator, before being appointed as UCLPartners Chief Executive Officer in February 2022.

Chris undertook specialist training in nephrology, critical care and internal medicine, and continues to practise as a consultant nephrologist at University College London and Royal Free Hospitals, where he is also Honorary Associate Professor of Nephrology at the UCL Centre for Nephrology.

He undertook research training in renal disease, genetics and physiology at UCLH and INSERM Paris. He has remained active in research through clinical trials, health services research and the use of artificial intelligence in predicting acute renal disease. He has a strong interest in digital health, technology and data science and was previously a senior clinical advisor to DeepMind Health and Google Health.

Chris was speciality training director and clinical lead for nephrology at the Royal Free. From 2013-2017 he was Royal Free associate medical director for patient safety, clinically leading a large patient safety improvement programme and quality governance and integration across the Royal Free hospitals. From 2017-2021 Chris was Divisional Clinical Director of Emergency Services at UCLH and was responsible for the emergency department (ED), urgent treatment centre, acute mental health pathway, children and young people’s ED, same day emergency care acute medicine and the medical enhanced care unit. In this role he oversaw a programme of service transformation, workforce development, full-digitisation, estates redevelopment and clinically led the UCLH COVID-19 emergency care response.

Chris co-founded and chaired London Acute Kidney Injury (AKI) Network. From 2014-2016 Chris clinically led the UCLPartners Patient Safety Programme AKI Improvement Collaborative. This programme extended across nine acute trusts and led to significant improvements in AKI recognition, recovery and mortality. Chris was secondary care lead for urgent and emergency care for the North Central London STP from 2017-2020. He has advised NICE and HQUIP and was member of the AKI National programme board. He is a fellow of the Royal College of Physicians.